Veradigm Operating Margin 2012-2022 | MDRX
Current and historical operating margin for Veradigm (MDRX) over the last 10 years. The current operating profit margin for Veradigm as of December 31, 2022 is 0.00%.
| Veradigm Operating Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Operating Income | Operating Margin |
| 2022-12-31 | $0.59B | $-0.03B | -4.41% |
| 2022-09-30 | $0.60B | $0.06B | 10.10% |
| 2022-06-30 | $0.60B | $0.05B | 9.05% |
| 2022-03-31 | $0.59B | $0.08B | 12.95% |
| 2021-12-31 | $0.58B | $0.08B | 13.32% |
| 2021-09-30 | $-0.14B | $0.11B | -81.43% |
| 2021-06-30 | $0.08B | $0.09B | 104.94% |
| 2021-03-31 | $0.31B | $0.04B | 13.92% |
| 2020-12-31 | $0.56B | $0.01B | 1.44% |
| 2020-09-30 | $1.43B | $-0.17B | -12.11% |
| 2020-06-30 | $1.51B | $-0.16B | -10.56% |
| 2020-03-31 | $1.58B | $-0.13B | -8.16% |
| 2019-12-31 | $1.63B | $-0.10B | -6.07% |
| 2019-09-30 | $1.63B | $-0.09B | -5.58% |
| 2019-06-30 | $1.62B | $-0.09B | -5.81% |
| 2019-03-31 | $1.62B | $-0.16B | -9.85% |
| 2018-12-31 | $1.62B | $-0.17B | -10.45% |
| 2018-09-30 | $1.52B | $-0.11B | -7.39% |
| 2018-06-30 | $1.53B | $-0.09B | -5.68% |
| 2018-03-31 | $1.52B | $-0.01B | -0.40% |
| 2017-12-31 | $1.50B | $0.01B | 0.80% |
| 2017-09-30 | $1.55B | $0.08B | 4.97% |
| 2017-06-30 | $1.49B | $0.07B | 4.62% |
| 2017-03-31 | $1.45B | $0.07B | 4.61% |
| 2016-12-31 | $1.39B | $0.07B | 4.90% |
| 2016-09-30 | $1.47B | $0.07B | 4.83% |
| 2016-06-30 | $1.43B | $0.06B | 4.40% |
| 2016-03-31 | $1.40B | $0.05B | 3.58% |
| 2015-12-31 | $1.39B | $0.03B | 2.31% |
| 2015-09-30 | $1.38B | $0.01B | 0.72% |
| 2015-06-30 | $1.37B | $-0.02B | -1.31% |
| 2015-03-31 | $1.37B | $-0.03B | -2.41% |
| 2014-12-31 | $1.38B | $-0.04B | -2.83% |
| 2014-09-30 | $1.39B | $-0.07B | -4.90% |
| 2014-06-30 | $1.37B | $-0.09B | -6.71% |
| 2014-03-31 | $1.37B | $-0.11B | -8.13% |
| 2013-12-31 | $1.37B | $-0.13B | -9.25% |
| 2013-09-30 | $1.37B | $-0.13B | -9.18% |
| 2013-06-30 | $1.40B | $-0.07B | -5.27% |
| 2013-03-31 | $1.43B | $-0.03B | -1.96% |
| 2012-12-31 | $1.45B | $0.01B | 0.90% |
| 2012-09-30 | $1.48B | $0.09B | 5.80% |
| 2012-06-30 | $1.49B | $0.11B | 7.46% |
| 2012-03-31 | $1.47B | $0.13B | 8.48% |
| 2011-12-31 | $1.44B | $0.14B | 9.42% |
| 2011-09-30 | $1.37B | $0.10B | 7.29% |
| 2011-06-30 | $1.25B | $0.07B | 5.20% |
| 2011-03-31 | $1.08B | $0.05B | 4.98% |
| 2010-09-30 | $0.62B | $0.05B | 8.43% |
| 2010-06-30 | $0.56B | $0.09B | 15.32% |
| 2010-03-31 | $0.53B | $0.09B | 17.07% |
| 2010-02-28 | $0.51B | $0.08B | 15.76% |
| 2009-09-30 | $0.49B | $0.07B | 13.65% |
| 2009-08-31 | $0.46B | $0.04B | 7.69% |
| 2009-02-28 | $0.47B | $0.03B | 5.59% |
| 2008-11-30 | $0.39B | $0.01B | 2.07% |
| 2008-08-31 | $0.25B | $0.02B | 6.07% |
| 2008-06-30 | $0.25B | $0.02B | 8.76% |
| 2008-03-31 | $0.34B | $0.06B | 18.13% |
| 2008-02-29 | $0.34B | $0.07B | 20.00% |
| 2007-12-31 | $0.31B | $0.06B | 18.85% |
| 2007-11-30 | $0.41B | $0.04B | 9.00% |
| 2007-09-30 | $0.38B | $0.04B | 9.21% |
| 2007-06-30 | $0.37B | $0.04B | 9.36% |
| 2007-05-31 | $0.37B | $0.03B | 9.29% |
| 2007-03-31 | $0.25B | $0.03B | 9.96% |
| 2006-12-31 | $0.23B | $0.02B | 8.77% |
| 2006-09-30 | $0.20B | $0.02B | 8.08% |
| 2006-06-30 | $0.17B | $0.01B | 7.78% |
| 2006-03-31 | $0.14B | $0.01B | 7.30% |
| 2005-12-31 | $0.12B | $0.01B | 7.44% |
| 2005-09-30 | $0.11B | $0.01B | 7.08% |
| 2005-06-30 | $0.11B | $0.01B | 5.56% |
| 2005-03-31 | $0.10B | $0.01B | 4.81% |
| 2004-12-31 | $0.10B | $0.00B | 3.96% |
| 2004-09-30 | $0.10B | $0.00B | 2.02% |
| 2004-06-30 | $0.10B | 0 | 0.00% |
| 2004-03-31 | $0.09B | $0.00B | -3.37% |
| 2003-12-31 | $0.09B | $-0.01B | -5.81% |
| 2003-09-30 | $0.08B | $-0.01B | -8.54% |
| 2003-06-30 | $0.08B | $-0.01B | -12.50% |
| 2003-03-31 | $0.08B | $-0.01B | -16.25% |
| 2002-12-31 | $0.08B | $-0.02B | -22.78% |
| 2002-09-30 | $0.08B | $-0.03B | -33.33% |
| 2002-06-30 | $0.07B | $-0.42B | -566.22% |
| 2002-03-31 | $0.07B | $-0.45B | -609.59% |
| 2001-12-31 | $0.07B | $-0.47B | -666.20% |
| 2001-09-30 | $0.07B | $-0.48B | -684.29% |
| 2001-06-30 | $0.07B | $-0.10B | -143.48% |
| 2001-03-31 | $0.06B | $-0.10B | -153.23% |
| 2000-12-31 | $0.06B | $-0.07B | -121.82% |
| 2000-09-30 | $0.05B | $-0.06B | -126.67% |
| 2000-06-30 | $0.04B | $-0.05B | -121.62% |
| 2000-03-31 | $0.03B | $-0.02B | -67.74% |
| 1999-12-31 | $0.03B | $-0.02B | -59.26% |
| 1999-06-30 | $0.02B | $0.00B | 5.56% |
| 1999-03-31 | $0.02B | $0.01B | 55.56% |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.587B | $0.594B |
| Veradigm Inc. is a healthcare technology company which drives value through its combination of platforms, data, expertise, connectivity and scale. Its network features a dynamic community of solutions and partners providing advanced insights, technology and data-driven solutions. Veradigm Inc., formerly known as Allscripts Healthcare Solutions Inc., is based in CHICAGO. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $42.703B | 42.61 |
| Tempus AI (TEM) | United States | $14.500B | 0.00 |
| 10x Genomics (TXG) | United States | $10.029B | 0.00 |
| Hinge Health (HNGE) | United States | $7.643B | 73.43 |
| Hims & Hers Health (HIMS) | United States | $6.507B | 0.00 |
| Doximity (DOCS) | United States | $4.736B | 29.20 |
| Heartflow (HTFL) | United States | $4.310B | 0.00 |
| IRhythm Holdings (IRTC) | United States | $3.684B | 242.93 |
| Privia Health (PRVA) | United States | $2.566B | 95.67 |
| Clover Health Investments (CLOV) | United States | $2.411B | 0.00 |
| Schrodinger (SDGR) | United States | $2.232B | 0.00 |
| Butterfly Network (BFLY) | United States | $2.120B | 0.00 |
| Inspire Medical Systems (INSP) | United States | $2.103B | 32.04 |
| Omnicell (OMCL) | United States | $1.484B | 21.18 |
| Azenta (AZTA) | United States | $1.473B | 80.07 |
| Enovis (ENOV) | United States | $1.027B | 5.31 |
| Talkspace (TALK) | United States | $0.879B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.716B | 0.00 |
| Phreesia (PHR) | United States | $0.638B | 34.27 |
| Fulgent Genetics (FLGT) | United States | $0.601B | 0.00 |
| Claritev (CTEV) | United States | $0.538B | 0.00 |
| Carlsmed (CARL) | United States | $0.420B | 0.00 |
| Evolent Health (EVH) | United States | $0.415B | 0.00 |
| Senseonics Holdings (SENS) | United States | $0.394B | 0.00 |
| CapsoVision (CV) | United States | $0.317B | 0.00 |
| Standard BioTools (LAB) | United States | $0.287B | 0.00 |
| American Well (AMWL) | United States | $0.226B | 0.00 |
| KORU Medical Systems (KRMD) | United States | $0.148B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.135B | 0.00 |
| Insight Molecular Diagnostics (IMDX) | United States | $0.129B | 0.00 |
| CareCloud (CCLD) | United States | $0.094B | 6.94 |
| Pulmonx (LUNG) | United States | $0.085B | 0.00 |
| Zepp Health (ZEPP) | Netherlands | $0.065B | 0.00 |
| Outset Medical (OM) | United States | $0.058B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.058B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.057B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.052B | 0.00 |
| Precipio (PRPO) | United States | $0.047B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.033B | 0.00 |
| 111 (YI) | China | $0.031B | 0.00 |
| Evaxion - (EVAX) | Denmark | $0.027B | 0.00 |
| HeartBeam (BEAT) | United States | $0.024B | 0.00 |
| HeartSciences (HSCS) | United States | $0.023B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.020B | 0.00 |
| DataMeds AI (MEDS) | United States | $0.015B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.011B | 0.00 |
| Lunai Bioworks (LNAI) | United States | $0.010B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.009B | 0.00 |
| ITonic Holdings (ITOC) | China | $0.005B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.001B | 0.00 |
| PROFUSA (PFSA) | United States | $0.001B | 0.00 |
| Zhongchao (ZCMD) | China | $0.001B | 0.00 |
| TruBridge (TBRG) | United States | $0.000B | 0.00 |